{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17320857", "DateCompleted": {"Year": "2007", "Month": "06", "Day": "13"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2007", "Month": "02", "Day": "01"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0014-2999", "JournalIssue": {"Volume": "562", "Issue": "1-2", "PubDate": {"Year": "2007", "Month": "May", "Day": "07"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism.", "Pagination": {"StartPage": "155", "EndPage": "163", "MedlinePgn": "155-63"}, "Abstract": {"AbstractText": ["The anti-inflammatory activities of some medicinal plants are attributed to their contents of sesquiterpene lactones. In the present study, the anti-inflammatory and anti-nociceptive activity of a sesquiterpene lactone isolated from Viguiera robusta, budlein A in mice was investigated. The treatment with budlein A dose--(1.0-10.0 mg/kg, p.o., respectively) dependently inhibited the carrageenan-induced: i. neutrophil migration to the peritoneal cavity (2-52%), ii. neutrophil migration to the paw skin tissue (32-74%), iii. paw oedema (13-74%) and iv. mechanical hypernociception (2-58%) as well as the acetic acid-induced writhings (0-66%). Additionally, budlein A (10.0 mg/kg) treatment inhibited the mechanical hypernociception-induced by tumour necrosis factor (TNF-alpha, 36%), Keratinocyte-derived chemokine (KC, 37%) and Interleukin-1beta (IL-1beta, 28%), but not of prostaglandin E(2) or dopamine. Budlein A also inhibited the carrageenan-induced release of TNF-alpha (52%), KC (70%) and IL-1beta (59%). Furthermore, an 8 days treatment with budlein A inhibited Complete Freund's adjuvant (10 microl/paw)-induced hypernociception, paw oedema and paw skin myeloperoxidase activity increase while not affecting the motor performance or myeloperoxidase activity in the stomach. Concluding, the present data suggest that budlein A presents anti-inflammatory and antinociceptive property in mice by a mechanism dependent on inhibition of cytokines production. It supports the potential beneficial effect of orally administered budlein A in inflammatory diseases involving cytokine-mediated nociception, oedema and neutrophil migration."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, S\u00e3o Paulo, Avenida Bandeirantes, 3900, 14049-900-Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil."}], "Identifier": [], "LastName": "Val\u00e9rio", "ForeName": "Daniel A R", "Initials": "DA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cunha", "ForeName": "Thiago M", "Initials": "TM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Arakawa", "ForeName": "Nilton S", "Initials": "NS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lemos", "ForeName": "Henrique P", "Initials": "HP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Da Costa", "ForeName": "Fernando B", "Initials": "FB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Parada", "ForeName": "Carlos A", "Initials": "CA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ferreira", "ForeName": "Sergio H", "Initials": "SH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cunha", "ForeName": "Fernando Q", "Initials": "FQ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Verri", "ForeName": "Waldiceu A", "Initials": "WA", "Suffix": "Jr"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Analgesics"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Lactones"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "budlein A"}, {"RegistryNumber": "9000-07-1", "NameOfSubstance": "Carrageenan"}, {"RegistryNumber": "9007-81-2", "NameOfSubstance": "Freund's Adjuvant"}, {"RegistryNumber": "K7Q1JQR04M", "NameOfSubstance": "Dinoprostone"}, {"RegistryNumber": "VTD58H1Z2X", "NameOfSubstance": "Dopamine"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Analgesics"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Asteraceae"}, {"QualifierName": ["drug effects"], "DescriptorName": "Behavior, Animal"}, {"QualifierName": ["toxicity"], "DescriptorName": "Carrageenan"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": ["toxicity"], "DescriptorName": "Dinoprostone"}, {"QualifierName": ["toxicity"], "DescriptorName": "Dopamine"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Edema"}, {"QualifierName": ["toxicity"], "DescriptorName": "Freund's Adjuvant"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Hindlimb"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Inflammation"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Lactones"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["chemically induced", "physiopathology", "prevention & control"], "DescriptorName": "Pain"}, {"QualifierName": ["pathology"], "DescriptorName": "Peritoneal Cavity"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Skin"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2006", "Month": "9", "Day": "4"}, {"Year": "2006", "Month": "12", "Day": "14"}, {"Year": "2007", "Month": "1", "Day": "16"}, {"Year": "2007", "Month": "2", "Day": "27", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "6", "Day": "15", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "2", "Day": "27", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17320857", "10.1016/j.ejphar.2007.01.029", "S0014-2999(07)00075-1"]}}], "PubmedBookArticle": []}